NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/12/2023
Voltar para busca
Dado oficial do USPTO
TEVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
19/12/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
20/10/2020
Data de registro
19/12/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/12/2023
Última transação
19/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/11/2013
Primeiro uso no comércio
01/11/2013
Código do desenho
3
Tipo de titular
99
Localização do titular
Tel Aviv, IL
Examinador
HOWELL,MATTHEW PATTERSON
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of two curved band designs that begins at the bottom center of an outlined rectangle and rise up toward the upper right hand corner of the rectangle. In the center of the curved band design is a large circle with an outline around the left side. In the bottom right hand corner is the word ''TEVA'' in lower case letters. The ''V'' in the word ''TEVA'' is formed by 2 leaf shapes. The entire mark is outlined by a thin line in the shape of a rectangle.
Titulares e representantes
Titulares
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Representantes
Laurence Rickles
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tractgastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that supportencourage and promote bone strength; Pharmaceutical preparations that supportencourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparationsinjectable contraceptives; Pharmaceutical preparationscontraceptive preparations; Pharmaceutical preparationsfertility enhancement preparations; Pharmaceutical preparationshormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
19/12/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13/11/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/11/2023
IUAF
USE AMENDMENT FILED
08/11/2023
EISU
TEAS STATEMENT OF USE RECEIVED
08/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/05/2023
EX4G
SOU EXTENSION 4 GRANTED
28/04/2023
EXT4
SOU EXTENSION 4 FILED
28/04/2023
EEXT
SOU TEAS EXTENSION RECEIVED
28/04/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/11/2022
EX3G
SOU EXTENSION 3 GRANTED
02/11/2022
EXT3
SOU EXTENSION 3 FILED
02/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/11/2022
EX3M
SOU EXTENSION 3 DENIAL LETTER PREPARED
17/05/2022
EX3D
SOU EXTENSION 3 DENIAL LETTER PREPARED
17/05/2022
EXT3
SOU EXTENSION 3 FILED
17/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/05/2022
EX2G
SOU EXTENSION 2 GRANTED
09/05/2022
EXT2
SOU EXTENSION 2 FILED
09/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/11/2021
EX1G
SOU EXTENSION 1 GRANTED
05/11/2021
EXT1
SOU EXTENSION 1 FILED
05/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/11/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/03/2021
PUBO
PUBLISHED FOR OPPOSITION
16/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/02/2021
DOCK
ASSIGNED TO EXAMINER
05/02/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2020
NWAP
NEW APPLICATION ENTERED
23/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TEVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.